Henlius issues 1.71 million new H shares for 2025 RSU scheme, expanding share base by 0.49%

Bulletin Express06-11 18:03

Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 11 June 2026 that it has allotted and issued 1.71 million new H shares to the trustee of its 2025 H Share Restricted Share Unit (RSU) Scheme. The new shares, issued at RMB 1 per share, are intended for the future vesting of RSUs granted under the scheme.

Prior to the issuance, Henlius had 346.07 million H shares outstanding. The new allotment increases the total to 347.78 million shares, representing a 0.49% expansion of issued share capital.

The company confirmed that the issuance was duly authorized by the board, all funds were received, and the transaction complied with Hong Kong Stock Exchange listing rules and relevant regulatory requirements. No share repurchases, redemptions, or on-market sales of treasury shares were reported as part of this disclosure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144732181?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144732181","market":"hk","top_or_hot":-1,"title":"Henlius issues 1.71 million new H shares for 2025 RSU scheme, expanding share base by 0.49%","media":"Bulletin Express","content":"<p>Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 11 June 2026 that it has allotted and issued 1.71 million new H shares to the trustee of its 2025 H Share Restricted Share Unit (RSU) Scheme. The new shares, issued at RMB 1 per share, are intended for the future vesting of RSUs granted under the scheme.</p>\n<p>Prior to the issuance, Henlius had 346.07 million H shares outstanding. The new allotment increases the total to 347.78 million shares, representing a 0.49% expansion of issued share capital.</p>\n<p>The company confirmed that the issuance was duly authorized by the board, all funds were received, and the transaction complied with Hong Kong Stock Exchange listing rules and relevant regulatory requirements. No share repurchases, redemptions, or on-market sales of treasury shares were reported as part of this disclosure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Henlius issues 1.71 million new H shares for 2025 RSU scheme, expanding share base by 0.49%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHenlius issues 1.71 million new H shares for 2025 RSU scheme, expanding share base by 0.49%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 11 June 2026 that it has allotted and issued 1.71 million new H shares to the trustee of its 2025 H Share Restricted Share Unit (RSU) Scheme. The new shares, issued at RMB 1 per share, are intended for the future vesting of RSUs granted under the scheme.</p>\n<p>Prior to the issuance, Henlius had 346.07 million H shares outstanding. The new allotment increases the total to 347.78 million shares, representing a 0.49% expansion of issued share capital.</p>\n<p>The company confirmed that the issuance was duly authorized by the board, all funds were received, and the transaction complied with Hong Kong Stock Exchange listing rules and relevant regulatory requirements. No share repurchases, redemptions, or on-market sales of treasury shares were reported as part of this disclosure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02696","symbol_name":"复宏汉霖","start_time":0,"source_url":"","article_id":"1144732181","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144732181","pubTimestamp":1781172193,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 11 June 2026 that it has allotted and issued 1.71 million new H shares to the trustee of its 2025 H Share Restricted Share Unit (RSU) Scheme. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02696":"复宏汉霖"},"translate_title":"复宏汉霖就2025年受限制股份单位计划发行171万股新H股，股份基础扩大0.49%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02696":1},"content_text":"Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 11 June 2026 that it has allotted and issued 1.71 million new H shares to the trustee of its 2025 H Share Restricted Share Unit (RSU) Scheme. The new shares, issued at RMB 1 per share, are intended for the future vesting of RSUs granted under the scheme.\nPrior to the issuance, Henlius had 346.07 million H shares outstanding. The new allotment increases the total to 347.78 million shares, representing a 0.49% expansion of issued share capital.\nThe company confirmed that the issuance was duly authorized by the board, all funds were received, and the transaction complied with Hong Kong Stock Exchange listing rules and relevant regulatory requirements. No share repurchases, redemptions, or on-market sales of treasury shares were reported as part of this disclosure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144732181","isCrawlerRequest":true}